Currently, the only FDA-approved OTC weight loss drug is Alli, which uses a 60-milligram dose of orlistat versus 120 ...

The Danish drugmaker reported last year that a late-stage study in people who don’t have diabetes showed that the daily pill led to an average weight loss of 15% over 68 weeks, a similar result ...

Finding the right solution for weight loss can feel overwhelming, especially with so many options available. While ...

From helping prevent cancer and diabetes to improving mood and cognitive function, these four supplements have a host of ...

A daily diet pill has shown promising results in early trials, with participants losing an average of 13% of their body weight in 12 weeks compared to 6% in those taking the Wegovy injection.

Zmyra is known as the top over-the-counter alternative to Wegovy for weight loss. This natural supplement packs a punch with ...

A new weight loss pill developed by the maker of Ozempic and ... a GLP-1 receptor agonist that is used to treat diabetes and obesity. The phase one trial of amycretin, led by Novo Nordisk ...

Zmyra stands out as a potent natural over-the-counter alternative to Ozempic. It provides a comprehensive weight loss ...

Novo Nordisk was one of 10 companies with diabetes and weight loss drugs ... GPCR shares rose 8% in June after the company's GLP-1 weight loss pill glowed in mid-stage clinical trials.

From helping prevent cancer and diabetes to improving mood and cognitive function, these four supplements have a host of ...